Clinical Trial Update: Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -

View source ↗

Summary

Clinical trial update reporting 48-week special drug use surveillance of sodium risedronate tablets in patients with Osseous Paget's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osseous Paget Disease

Drugs mentioned

• Sodium risedronate tablets (risendronate sodium)

Snippet

Sponsor: Takeda | Conditions: Osseous Paget's Disease | Status: COMPLETED | Results posted: 2019-06-03